Novartis AG

Bristol Myers Squibb’s new executive vice president, chief medical officer and head of development Christian Massacesi will have the task of bringing new growth drivers to market amid loss-of-exclusiv

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Matchpoint Will Seek Out Oral

An Absence Of Worry When Johnson & Johnson kicked-off second-quarter earnings season for life science companies, black clouds hung over the sector. As the Trump administration chopped and changed

Having led calls for European countries to incentivize innovation by assigning higher value to medicines, Novartis CEO Vas Narasimhan has claimed that pharma companies would be less likely to launch t